TiumBio Co., Ltd. (KOSDAQ:321550)

TiumBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	185,400	112,386	240,562	302,627	461,602	496,808
Market Cap Growth	11.31%	-53.28%	-20.51%	-34.44%	-7.09%	19.98%
Enterprise Value	182,626	130,114	261,518	295,725	419,268	447,505
Last Close Price	6830.00	4315.00	9770.00	12600.00	19300.00	21100.00
PS Ratio	25.28	16.55	49.11	33.19	8127.16	473.63
PB Ratio	3.42	1.79	2.96	4.86	5.11	6.02
P/TBV Ratio	4.53	2.28	3.54	5.10	5.40	6.15
EV/Sales Ratio	24.90	19.16	53.38	32.44	7381.81	426.62
Debt / Equity Ratio	0.68	0.48	0.36	0.37	0.22	0.02
Asset Turnover	0.07	0.06	0.05	0.09	0.00	0.01
Quick Ratio	1.88	1.89	3.19	1.18	9.31	39.00
Current Ratio	2.16	2.15	3.48	1.34	9.38	39.32
Return on Equity (ROE)	-21.68%	-32.75%	-26.54%	-41.16%	-37.32%	-13.85%
Return on Assets (ROA)	-11.04%	-10.30%	-16.12%	-15.05%	-20.22%	-9.30%
Return on Capital (ROIC)	-12.80%	-11.52%	-17.78%	-16.41%	-21.12%	-9.43%
Earnings Yield	-5.66%	-18.37%	-7.45%	-9.86%	-6.85%	-2.44%
FCF Yield	-7.30%	-14.83%	-16.19%	-8.99%	-7.94%	-2.06%
Buyback Yield / Dilution	-11.99%	-5.91%	-1.79%	-0.63%	-1.39%	-17.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.